Sign in
PDB84 - HETEROGENEITY OF TREATMENT EFFECT IN THE DIABETES PREVENTION PROGRAM: HIGH BASELINE RISK OF DEVELOPING DIABETES MAY PROVIDE A PLACE FOR METFORMIN IN DIABETES PREVENTION THAT USING OVERALL SAMPLE AVERAGE COSTS AND EFFECTS CONCEALS
Journal article   Open access  Peer reviewed

PDB84 - HETEROGENEITY OF TREATMENT EFFECT IN THE DIABETES PREVENTION PROGRAM: HIGH BASELINE RISK OF DEVELOPING DIABETES MAY PROVIDE A PLACE FOR METFORMIN IN DIABETES PREVENTION THAT USING OVERALL SAMPLE AVERAGE COSTS AND EFFECTS CONCEALS

S. Alolayan, T. Eguale, A. Segal, J. Doucette and B. Rittenhouse
Value in health, Vol.21, pp.S132-S133
10/2018
url
https://doi.org/10.1016/j.jval.2018.09.789View
Published (Version of record) Open

Metrics

1 Record Views

Details